Empirical Bayes versus fully Bayesian analysis of geographical variation in disease risk.

Abstract:

:This paper reviews methods for mapping geographical variation in disease incidence and mortality. Recent results in Bayesian hierarchical modelling of relative risk are discussed. Two approaches to relative risk estimation, along with the related computational procedures, are described and compared. The first is an empirical Bayes approach that uses a technique of penalized log-likelihood maximization; the second approach is fully Bayesian, and uses an innovative stochastic simulation technique called the Gibbs sampler. We chose to map geographical variation in breast cancer and Hodgkin's disease mortality as observed in all the health care districts of Sardinia, to illustrate relevant problems, methods and techniques.

journal_name

Stat Med

journal_title

Statistics in medicine

authors

Bernardinelli L,Montomoli C

doi

10.1002/sim.4780110802

subject

Has Abstract

pub_date

1992-06-15 00:00:00

pages

983-1007

issue

8

eissn

0277-6715

issn

1097-0258

journal_volume

11

pub_type

杂志文章
  • An easy-to-implement approach for analyzing case-control and case-only studies assuming gene-environment independence and Hardy-Weinberg equilibrium.

    abstract::The case-control study is a simple and an useful method to characterize the effect of a gene, the effect of an exposure, as well as the interaction between the two. The control-free case-only study is yet an even simpler design, if interest is centered on gene-environment interaction only. It requires the sometimes pl...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.4028

    authors: Lee WC,Wang LY,Cheng KF

    更新日期:2010-10-30 00:00:00

  • The ghosts of departed quantities: approaches to dealing with observations below the limit of quantitation.

    abstract::A common but not necessarily logical requirement in drug development is that a 'limit of quantitation' be set for chemical assays and that observations that fall below the limit should not be treated as real data but should be labelled as below the limit and set aside for special treatment. We examine five of seven ap...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.5515

    authors: Senn S,Holford N,Hockey H

    更新日期:2012-12-30 00:00:00

  • On the relationship between association and surrogacy when both the surrogate and true endpoint are binary outcomes.

    abstract::The relationship between association and surrogacy has been the focus of much debate in the surrogate marker literature. Recently, the individual causal association (ICA) has been introduced as a metric of surrogacy in the causal inference framework, when both the surrogate and the true endpoint are normally distribut...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.8698

    authors: Meyvisch P,Alonso A,Van der Elst W,Molenberghs G

    更新日期:2020-11-20 00:00:00

  • Compliance with quality of life data collection in the National Surgical Adjuvant Breast and Bowel Project (NSABP) Breast Cancer Prevention Trial.

    abstract::This paper describes compliance with the completion of a quality of life questionnaire in the Breast Cancer Prevention Trial, a large multi-centre randomized trial that is studying the efficacy of Tamoxifen in preventing breast cancer. In the first 4875 women enrolled in the control arm of the study, there was a very ...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0258(19980315/15)17:5/7<613::ai

    authors: Ganz PA,Day R,Costantino J

    更新日期:1998-03-15 00:00:00

  • Estimation of mean sojourn time in breast cancer screening using a Markov chain model of both entry to and exit from the preclinical detectable phase.

    abstract::The sojourn time, time spent in the preclinical detectable phase (PCDP) for chronic diseases, for example, breast cancer, plays an important role in the design and assessment of screening programmes. Traditional methods to estimate it usually assume a uniform incidence rate of preclinical disease from a randomized con...

    journal_title:Statistics in medicine

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1002/sim.4780141404

    authors: Duffy SW,Chen HH,Tabar L,Day NE

    更新日期:1995-07-30 00:00:00

  • Bayesian approach to average power calculations for binary regression models with misclassified outcomes.

    abstract::We develop a simulation-based procedure for determining the required sample size in binomial regression risk assessment studies when response data are subject to misclassification. A Bayesian average power criterion is used to determine a sample size that provides high probability, averaged over the distribution of po...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.3505

    authors: Cheng D,Stamey JD,Branscum AJ

    更新日期:2009-02-28 00:00:00

  • Modelling age-specific risk: application to dementia.

    abstract::We give up-to-date methods for estimating the age-specific incidence of a disease and for estimating the effect of risk factors. We recommend taking age as the basic time scale of the analysis; then, the hazard function can be interpreted as the age-specific incidence of the disease. This choice raises a delayed entry...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0258(19980915)17:17<1973::aid-s

    authors: Commenges D,Letenneur L,Joly P,Alioum A,Dartigues JF

    更新日期:1998-09-15 00:00:00

  • Joint modeling longitudinal semi-continuous data and survival, with application to longitudinal medical cost data.

    abstract::It has been increasingly common to analyze simultaneously repeated measures and time to failure data. In this paper we propose a joint model when the repeated measures are semi-continuous, characterized by the presence of a large portion of zero values, as well as right skewness of non zero (positive) values. Examples...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.3497

    authors: Liu L

    更新日期:2009-03-15 00:00:00

  • Estimating the sample size for a t-test using an internal pilot.

    abstract::If the sample size for a t-test is calculated on the basis of a prior estimate of the variance then the power of the test at the treatment difference of interest is not robust to misspecification of the variance. We propose a t-test for a two-treatment comparison based on Stein's two-stage test which involves the use ...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0258(19990715)18:13<1575::aid-s

    authors: Denne JS,Jennison C

    更新日期:1999-07-15 00:00:00

  • Comparison between splines and fractional polynomials for multivariable model building with continuous covariates: a simulation study with continuous response.

    abstract::In observational studies, many continuous or categorical covariates may be related to an outcome. Various spline-based procedures or the multivariable fractional polynomial (MFP) procedure can be used to identify important variables and functional forms for continuous covariates. This is the main aim of an explanatory...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.5639

    authors: Binder H,Sauerbrei W,Royston P

    更新日期:2013-06-15 00:00:00

  • Modelling heterogeneity in clustered count data with extra zeros using compound Poisson random effect.

    abstract::In medical and health studies, heterogeneities in clustered count data have been traditionally modeled by positive random effects in Poisson mixed models; however, excessive zeros often occur in clustered medical and health count data. In this paper, we consider a three-level random effects zero-inflated Poisson model...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.3619

    authors: Ma R,Hasan MT,Sneddon G

    更新日期:2009-08-15 00:00:00

  • ML and REML estimation in survival analysis with time dependent correlated frailty.

    abstract::In the study of multiple failure times for the same subjects, for example, recurrent infections for patients with a given disease, there are often subject effects, that is, subjects have different risks that cannot be explained by known covariates. Standard methods, which ignore subject effects, lead to overestimation...

    journal_title:Statistics in medicine

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1002/(sici)1097-0258(19980615)17:11<1201::aid-s

    authors: Yau KK,McGilchrist CA

    更新日期:1998-06-15 00:00:00

  • Adjusting for misclassification in a stratified biomarker clinical trial.

    abstract::Clinical trials utilizing predictive biomarkers have become a research focus in personalized medicine. We investigate the effects of biomarker misclassification on the design and analysis of stratified biomarker clinical trials. For a variety of inference problems including marker-treatment interaction in particular, ...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.6164

    authors: Liu C,Liu A,Hu J,Yuan V,Halabi S

    更新日期:2014-08-15 00:00:00

  • Discrimination and other statistical intervals for the interpretation of in vivo patient monitoring data.

    abstract::A calibration line is used to define the relationship between a new clinical technique and a standard in vitro laboratory methodology. Discrimination intervals quantify the reliability of inverse estimates obtained from the calibration line. Applied to transcutaneous PCO2 monitoring, a new in vivo measurement, discrim...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.4780050407

    authors: Kost GJ

    更新日期:1986-07-01 00:00:00

  • A Bayesian hierarchical nonlinear model for assessing the association between genetic variation and drug cytotoxicity.

    abstract::Non-tumor cell-based model systems have recently gained interest in pharmacogenetic research as a hypothesis generating tool. The hypotheses generated from these model systems can be followed up in functional studies, or tested in individuals taking the same investigational agents. The current cellular phenotypes (e.g...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.3649

    authors: Fridley BL,Jenkins G,Schaid DJ,Wang L

    更新日期:2009-09-20 00:00:00

  • Assessing the goodness-of-fit of the Laird and Ware model--an example: the Jimma Infant Survival Differential Longitudinal Study.

    abstract::The Jimma Infant Survival Differential Longitudinal Study is an Ethiopian study, set up to establish risk factors affecting infant survival and to investigate socio-economic, maternal and infant-rearing factors that contribute most to the child's early survival. Here, a subgroup of about 1500 children born in Jimma to...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0258(19990415)18:7<835::aid-sim

    authors: Lesaffre E,Asefa M,Verbeke G

    更新日期:1999-04-15 00:00:00

  • A simple method for estimating the odds ratio in matched case-control studies with incomplete paired data.

    abstract::Paired data from matched case-control studies are commonly used to estimate the association between the exposure to a risk factor and the occurrence of a disease. The odds ratio is typically used to quantify this association. Difficulties in estimating the true odds ratio with matched pairs arise, however, when the ex...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.5355

    authors: Miller KM,Looney SW

    更新日期:2012-11-30 00:00:00

  • Conflicts of interest in data monitoring of industry versus publicly financed clinical trials.

    abstract::The FDA Guidance, while highly appropriate for industry sponsored trials, need not be imposed on publicly (e.g. NIH) financed clinical trials. While the potential for conflicts of interest exist in the latter, they are in general manageable and pose an acceptable low risk of threatening the integrity of a study. Howev...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.1787

    authors: Lachin JM

    更新日期:2004-05-30 00:00:00

  • Using marginal structural models to adjust for treatment drop-in when developing clinical prediction models.

    abstract::Clinical prediction models (CPMs) can inform decision making about treatment initiation, which requires predicted risks assuming no treatment is given. However, this is challenging since CPMs are usually derived using data sets where patients received treatment, often initiated postbaseline as "treatment drop-ins." Th...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.7913

    authors: Sperrin M,Martin GP,Pate A,Van Staa T,Peek N,Buchan I

    更新日期:2018-12-10 00:00:00

  • Memory and other properties of multiple test procedures generated by entangled graphs.

    abstract::Methods for addressing multiplicity in clinical trials have attracted much attention during the past 20 years. They include the investigation of new classes of multiple test procedures, such as fixed sequence, fallback and gatekeeping procedures. More recently, sequentially rejective graphical test procedures have bee...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.5711

    authors: Maurer W,Bretz F

    更新日期:2013-05-10 00:00:00

  • Pros and cons of permutation tests in clinical trials.

    abstract::Hypothesis testing, in which the null hypothesis specifies no difference between treatment groups, is an important tool in the assessment of new medical interventions. For randomized clinical trials, permutation tests that reflect the actual randomization are design-based analyses for such hypotheses. This means that ...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0258(20000530)19:10<1319::aid-s

    authors: Berger VW

    更新日期:2000-05-30 00:00:00

  • A hierarchical testing approach for detecting safety signals in clinical trials.

    abstract::Detecting safety signals in clinical trial safety data is known to be challenging due to high dimensionality, rare occurrence, weak signal, and complex dependence. We propose a new hierarchical testing approach for analyzing safety data from a typical randomized clinical trial. This approach accounts for the hierarchi...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.8495

    authors: Tan X,Chen BE,Sun J,Patel T,Ibrahim JG

    更新日期:2020-05-15 00:00:00

  • Determining the value of additional surrogate exposure data for improving the estimate of an odds ratio.

    abstract::We consider the design of both cohort and case-control studies in which an initial ('stage 1') sample of complete data on an error-free disease indicator (D), a correct ('gold standard') dichotomous exposure measurement (X) and an error-prone exposure measurement (Z) are available. We calculate the amount of additiona...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.4780142307

    authors: Dahm PF,Gail MH,Rosenberg PS,Pee D

    更新日期:1995-12-15 00:00:00

  • Considerations for analysis of time-to-event outcomes measured with error: Bias and correction with SIMEX.

    abstract::For time-to-event outcomes, a rich literature exists on the bias introduced by covariate measurement error in regression models, such as the Cox model, and methods of analysis to address this bias. By comparison, less attention has been given to understanding the impact or addressing errors in the failure time outcome...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.7554

    authors: Oh EJ,Shepherd BE,Lumley T,Shaw PA

    更新日期:2018-04-15 00:00:00

  • Randomization tests for multiarmed randomized clinical trials.

    abstract::We examine the use of randomization-based inference for analyzing multiarmed randomized clinical trials, including the application of conditional randomization tests to multiple comparisons. The view is taken that the linkage of the statistical test to the experimental design (randomization procedure) should be recogn...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.8418

    authors: Wang Y,Rosenberger WF,Uschner D

    更新日期:2020-02-20 00:00:00

  • Nonparametric sequential evaluation of diagnostic biomarkers.

    abstract::We consider evaluation and comparison of the diagnostic accuracy of biomarkers with continuous test outcomes, possibly correlated due to repeated measurements. We develop nonparametric group sequential testing procedures to evaluate and compare the area of biomarkers under their receiver operating characteristic curve...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.3203

    authors: Liu A,Wu C,Schisterman EF

    更新日期:2008-05-10 00:00:00

  • A recycling framework for the construction of Bonferroni-based multiple tests.

    abstract::In this paper we describe Bonferroni-based multiple testing procedures (MTPs) as strategies to split and recycle test mass. Here, 'test mass' refers to (parts of) the nominal level alpha at which the family-wise error rate is controlled. Briefly, test mass is split between different null hypotheses, and whenever a nul...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.3513

    authors: Burman CF,Sonesson C,Guilbaud O

    更新日期:2009-02-28 00:00:00

  • Bivariate random change point models for longitudinal outcomes.

    abstract::Epidemiologic and clinical studies routinely collect longitudinal measures of multiple outcomes, including biomarker measures, cognitive functions, and clinical symptoms. These longitudinal outcomes can be used to establish the temporal order of relevant biological processes and their association with the onset of cli...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.5557

    authors: Yang L,Gao S

    更新日期:2013-03-15 00:00:00

  • A pathway analysis method for genome-wide association studies.

    abstract::For genome-wide association studies, we propose a new method for identifying significant biological pathways. In this approach, we aggregate data across single-nucleotide polymorphisms to obtain summary measures at the gene level. We then use a hierarchical Bayesian model, which takes the gene-level summary measures a...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.4477

    authors: Shahbaba B,Shachaf CM,Yu Z

    更新日期:2012-05-10 00:00:00

  • The relative importance of prognostic factors in studies of survival.

    abstract::The relative importance of prognostic factors in regression can be measured either by standardized regression coefficients or by percentages of explained variation in a dependent variable. One advantage of using explained variation is the direct comparability of qualitative prognostic factors with others, or of groups...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.4780122413

    authors: Schemper M

    更新日期:1993-12-30 00:00:00